Search Results

Aprecia, a precision drug delivery company, has partnered with the research and development experts at Battelle to develop groundbreaking 3D printing platforms with the potential to transform the way medicines are developed, manufactured, distributed, and administered.

Aprecia Pharmaceuticals today announced Owen Murray as its Chief Executive Officer.

Aprecia Pharmaceuticals announced that it has hired Garry Hedgepeth as Vice President of Quality.

Glatt Pharmaceutical Services and Aprecia announce their joint effort to accelerate and expand the use of Glatt’s multiparticulate technologies through Aprecia’s 3DP manufacturing

The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.

Purdue University continues to make giant leaps in innovation with the recent 3D printing (3DP) equipment donation from its industry partner Aprecia Pharmaceuticals.

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms.

Battelle’s innovative design teams will focus on expanding the capabilities of Aprecia’s 3DP technology platform addressing important pharmaceutical product challenges through 3DP innovation

Aprecia, the 3DP Pharmaceutical Company, today announced the appointment of Kathi Rinesmith, R.Ph., MS as Senior Vice President of Regulatory Affairs.

WEST LAFAYETTE, Ind. and CINCINNATI , Feb. 20, 2020 /PRNewswire/ -- Healthcare is poised for a potential giant leap forward thanks to the 3D printing of medications. To advance the technology and science of 3D pharmaceutical printing, Purdue University’s College of Pharmacy and Aprecia Pharmaceuticals, LLC are launching a comprehensive collaboration on future 3DP pharmaceu